Literature DB >> 12549925

Distinct mechanisms by mutant presenilin 1 and 2 leading to increased intracellular levels of amyloid beta-protein 42 in Chinese hamster ovary cells.

Yue Qi1, Maho Morishima-Kawashima, Toru Sato, Rie Mitsumori, Yasuo Ihara.   

Abstract

To characterize the properties of presenilin (PS) 1- and PS2-associated gamma-secretases, we established stable transfectants overexpressing amyloid precursor protein and wild-type (wt) or a number of mutant (mt) PS1 or PS2. Quantification of the intracellular amyloid beta-protein (Abeta) levels in mtPS1 and mtPS2 cell lines revealed the presence of two subtypes. One group consists of N141I, M239V, and T122P mutations of the PS2 gene and homologous mutations of PS1, N135D and M233T. These mutations led to an increase in the intracellular Abeta42 levels and a concomitant decrease in the intracellular Abeta40 levels. A cell-free assay for Abeta production using the membranes prepared from these transfectants exhibited predominant cleavage at position Abeta42 with marginal production of Abeta40. The other group consists of M146L, H163R, and G384A mutations of PS1, leading only to an increase in the intracellular Abeta42 levels. While the intracellular Abeta levels in M146L cells were consistent with the results from cell-free Abeta production, H163R and G384A cells showed significant discrepancies between the intracellular Abeta levels and cell-free Abeta production. Thus, all the mtPS1/2 examined here result in increases in the intracellular Abeta42 levels. This suggests that the underlying mechanisms for this shared phenotype may be diverse.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12549925     DOI: 10.1021/bi0267590

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  15 in total

1.  Dissociation between the processivity and total activity of γ-secretase: implications for the mechanism of Alzheimer's disease-causing presenilin mutations.

Authors:  Omar Quintero-Monzon; Morgan M Martin; Marty A Fernandez; Christina A Cappello; Amanda J Krzysiak; Pamela Osenkowski; Michael S Wolfe
Journal:  Biochemistry       Date:  2011-09-30       Impact factor: 3.162

2.  Cleavage of amyloid precursor protein by an archaeal presenilin homologue PSH.

Authors:  Shangyu Dang; Shenjie Wu; Jiawei Wang; Hongbo Li; Min Huang; Wei He; Yue-Ming Li; Catherine C L Wong; Yigong Shi
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-02       Impact factor: 11.205

3.  Molecular determinants and thermodynamics of the amyloid precursor protein transmembrane domain implicated in Alzheimer's disease.

Authors:  Hao Wang; Laura Barreyro; Davide Provasi; Imane Djemil; Celia Torres-Arancivia; Marta Filizola; Iban Ubarretxena-Belandia
Journal:  J Mol Biol       Date:  2011-03-31       Impact factor: 5.469

Review 4.  The presenilin hypothesis of Alzheimer's disease: evidence for a loss-of-function pathogenic mechanism.

Authors:  Jie Shen; Raymond J Kelleher
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-29       Impact factor: 11.205

5.  Dissociated phenotypes in presenilin transgenic mice define functionally distinct gamma-secretases.

Authors:  Peter Mastrangelo; Paul M Mathews; M Azhar Chishti; Stephen D Schmidt; Yongjun Gu; Jing Yang; Matthew J Mazzella; Janaky Coomaraswamy; Patrick Horne; Bob Strome; Heather Pelly; Georges Levesque; Chris Ebeling; Ying Jiang; Ralph A Nixon; Richard Rozmahel; Paul E Fraser; Peter St George-Hyslop; George A Carlson; David Westaway
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-10       Impact factor: 11.205

6.  The Psen1-L166P-knock-in mutation leads to amyloid deposition in human wild-type amyloid precursor protein YAC transgenic mice.

Authors:  Ruben Vidal; Neeraja Sammeta; Holly J Garringer; Kumar Sambamurti; Leticia Miravalle; Bruce T Lamb; Bernardino Ghetti
Journal:  FASEB J       Date:  2012-03-29       Impact factor: 5.191

Review 7.  Loss-of-function presenilin mutations in Alzheimer disease. Talking Point on the role of presenilin mutations in Alzheimer disease.

Authors:  Bart De Strooper
Journal:  EMBO Rep       Date:  2007-02       Impact factor: 8.807

8.  Longer forms of amyloid beta protein: implications for the mechanism of intramembrane cleavage by gamma-secretase.

Authors:  Yue Qi-Takahara; Maho Morishima-Kawashima; Yu Tanimura; Georgia Dolios; Naoko Hirotani; Yuko Horikoshi; Fuyuki Kametani; Masahiro Maeda; Takaomi C Saido; Rong Wang; Yasuo Ihara
Journal:  J Neurosci       Date:  2005-01-12       Impact factor: 6.167

9.  Effects of human apolipoprotein E isoforms on the amyloid beta-protein concentration and lipid composition in brain low-density membrane domains.

Authors:  Maho Morishima-Kawashima; Xianlin Han; Yu Tanimura; Hiroki Hamanaka; Mariko Kobayashi; Takashi Sakurai; Minesuke Yokoyama; Koji Wada; Nobuyuki Nukina; Shinobu C Fujita; Yasuo Ihara
Journal:  J Neurochem       Date:  2007-05       Impact factor: 5.372

10.  Oxidative damage in brain from human mutant APP/PS-1 double knock-in mice as a function of age.

Authors:  Hafiz Mohmmad Abdul; Rukhsana Sultana; Daret K St Clair; William R Markesbery; D Allan Butterfield
Journal:  Free Radic Biol Med       Date:  2008-08-16       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.